Charles River Laboratories International, Inc. (CRL) vs Solventum Corporation (SOLV)

A side-by-side comparison of Charles River Laboratories International, Inc. and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnCRL vs SOLV

growth of $100 · dividends reinvested · last 2y
CRL +3.8% (+1.9%/yr)SOLV +9.3% (+4.6%/yr)SOLV compounded faster over this window
406080100120Start $10020252026$104$109
CRL SOLV

CRL vs SOLV: by the numbers

  • SOLV is the larger company ($15.38B vs $13.44B market cap).
  • SOLV is profitable (17.26% net margin) while CRL runs a net loss (-5.96%).
  • CRL grew revenue faster over the past five years (4.08% vs 2.72% CAGR).

Metrics side by side

Valuation

MetricCRLSOLV
P/E ratioN/A10.85
Forward P/E24.6512.41
P/S ratio3.361.85
P/B ratio4.733.21
EV / EBITDA20.567.12
FCF yield2.76%N/A

Profitability

MetricCRLSOLV
Gross margin32.24%54.69%
Operating margin12.35%24.99%
Net margin-5.96%17.26%
ROE-8.40%29.88%
ROIC7.72%15.85%

Growth (annualized)

MetricCRLSOLV
Revenue CAGR (5Y)4.08%2.72%
EPS CAGR (5Y)-47.86%6.26%
FCF CAGR (5Y)6.43%N/A
Total return CAGR (5Y)-8.79%N/A

Frequently asked

Which has grown faster, CRL or SOLV?
Over the past five years, CRL grew revenue faster — CRL at a 4.08% CAGR versus SOLV at 2.72%.
Is CRL or SOLV more profitable?
SOLV runs the higher net margin — CRL at -5.96% versus SOLV at 17.26%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.